QA: Genelux Corp in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001231457_2026_Genelux_Corp.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001231457, Genelux Corp

  xvar xval
0 AssetsCurrent 15,130,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,170,000
3 remainder_Assets 1,727,000
4 LiabilitiesCurrent 6,225,000
5 LiabilitiesNoncurrent 1,258,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,371,000
9 ResearchAndDevelopmentExpense 19,851,000
10 remainder_Expenses 0
11 remainder_Revenues 8,000
12 remainder_NetIncome 1,069,000
13 remainder_ComprehensiveNetIncome -55,000
  yvar yval
0 Assets 19,027,000
1 Liabilities 7,483,000
2 Expenses 33,222,000
3 Revenues 8,000
4 StockholdersEquity 11,544,000
5 NetIncome -32,145,000
6 ComprehensiveNetIncome -32,172,500
7 BaseVar 30,432,000
8 EconomicCapitalRatiobeforeLimitedLiability -0.529
9 EconomicCapitalRatio 1.38

Edgar->Model Mapping

Feature Distribution

Change over Time